Jun 23, 2020 7:00am EDT XORTX Announces Mr. Anthony J. Giovinazzo to Join as Special Advisor to the Board of Directors
May 19, 2020 9:38am EDT XORTX Provides Program Update Regarding XRx-008 for ADPKD and XRx-101 for Coronavirus / COVID-19 Programs
Apr 30, 2020 9:02am EDT XORTX Appoints Lonza for GMP Manufacturing and Formulation of XRx-101 (Oxypurinol) for Coronavirus / COVID-19 Clinical Trials
Mar 16, 2020 11:00am EDT XORTX Launches XRx-101 Following the Filing of a Provisional Patent to Potentially Treat Respiratory and Kidney Disease Injury Due to Coronavirus Infection
Mar 16, 2020 7:00am EDT XORTX Launches XRx-101, A New Program to Treat Coronavirus COVID-19 Infection